FENC
NASDAQ · Biotechnology
Fennec Pharmaceuticals Inc
$10.75
-0.28 (-2.54%)
Open$11.02
Previous Close$11.03
Day High$11.21
Day Low$10.69
52W High$10.59
52W Low$5.65
Volume—
Avg Volume267.1K
Market Cap365.43M
P/E Ratio—
EPS$-0.28
SectorBiotechnology
Analyst Ratings
Strong Buy
13 analysts
Price Target
+177.2% upside
Current
$10.75
$10.75
Target
$29.80
$29.80
$21.84
$29.80 avg
$37.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 52.96M | 74.30M | 77.18M |
| Net Income | -11,556,243 | -6,101,542 | -7,191,772 |
| Profit Margin | -21.8% | -8.2% | -9.3% |
| EBITDA | -9,851,112 | -9,610,170 | -10,191,915 |
| Free Cash Flow | — | -4,689,819 | -4,353,916 |
| Rev Growth | +207.2% | -7.2% | -5.1% |
| Debt/Equity | — | 0.51 | 0.45 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |